View in EDS HTML Full Text PDF Full Text

Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 mutations: A case report.

Saved in:
Bibliographic Details
Title: Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 mutations: A case report.
Authors: Zhong, Rui1 (AUTHOR), Li, Hui1 (AUTHOR), Liu, Yanling2 (AUTHOR), Zhang, Shuang3 (AUTHOR), Liu, Jingjing3 (AUTHOR), Huang, Zhicheng4 (AUTHOR), Cheng, Ying1,3 (AUTHOR) chengying@csco.org.cn
Source: Thoracic Cancer. Feb2020, Vol. 11 Issue 2, p456-460. 5p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17597706
DOI:10.1111/1759-7714.13286